Search results
Results from the WOW.Com Content Network
Japan is experiencing a record-setting number of streptococcal toxic shock syndrome (STSS) cases. STSS is a rare but severe complication of Group A Streptococcus infection, the same bacteria ...
Most infections are mild and require no therapy or only symptomatic treatment. Under research [1] Trypanosoma brucei: African sleeping sickness (African trypanosomiasis) Identification of trypanosomes in a sample by microscopic examination Fexinidazole by mouth or pentamidine by injection for T. b. gambiense.
There is a polyvalent inactivated vaccine against several types of Streptococcus including S. pyogenes called " vacuna antipiogena polivalente BIOL" it is recommended an administration in a series of 5 weeks. Two weekly applications are made at intervals of 2 to 4 days. The vaccine is produced by the Instituto Biológico Argentino. [44]
[103] [127] GBS infections in adults include urinary tract infection, skin and soft-tissue infection (skin and skin structure infection) bacteremia without focus, osteomyelitis, meningitis and endocarditis. [3] GBS infection in adults can be serious, and mortality is higher among adults than among neonates. [103]
Cases of a dangerous and highly fatal bacterial infection have reached record levels in Japan, official figures show, with experts so far unable to pinpoint the reason for the rise.
For example, contacts are only told that they have been exposed to a particular infection, but not informed of the person who was the source of the exposure. [9] In the United States, HIPAA is a legal measure for protecting health information. [54] This ensures sharing of only relevant information in the contact tracing process. [54]
Example of a workup algorithm of possible bacterial infection in cases with no specifically requested targets (non-bacteria, mycobacteria etc.), with most common situations and agents seen in a New England setting. Typically identification is done by growing the organism in a wide range of cultures which can take up to 48 hours.
This template is used to provide data for COVID-19 vaccine, COVID-19 pandemic by country and territory, and Deployment of COVID-19 vaccines. References [ edit ]